Загрузка...
Real-life effectiveness of fluticasone furoate/vilanterol after switching from fluticasone/salmeterol or budesonide/formoterol therapy in patients with symptomatic asthma: Relvar Ellipta for Real Asthma Control Study (RERACS study)
BACKGROUND: This study evaluated the efficacy of switching therapy from fluticasone propionate/salmeterol (FP/SM) or budesonide/formoterol (BD/FM) to fluticasone furoate and vilanterol (FF/VI) at the equivalent corticosteroid dose in a real-world setting. METHODS: A prospective, 3-month, open-label,...
Сохранить в:
| Опубликовано в: : | J Thorac Dis |
|---|---|
| Главные авторы: | , , , , |
| Формат: | Artigo |
| Язык: | Inglês |
| Опубликовано: |
AME Publishing Company
2020
|
| Предметы: | |
| Online-ссылка: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7330400/ https://ncbi.nlm.nih.gov/pubmed/32642091 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.21037/jtd-19-3913 |
| Метки: |
Добавить метку
Нет меток, Требуется 1-ая метка записи!
|